CLTX Shares Celtic Therapeutics
WATCH ASX
$0.01
—
Prices as of close 2026-10-27
CAR-T safety data may validate a differentiated oncology platform and attract partnering interest.
Future value: $0.03 (+150.00%) · 6-12 months
Signal breakdown
- ▸Expected Phase 1 glioblastoma safety data.
Is CLTX a buy right now?
Our screen: WATCH (score 0) — CAR-T safety data may validate a differentiated oncology platform and attract partnering interest.
Computed from end-of-day data; not personal advice.
Our track record with CLTX
First flagged in our daily picks as WATCH on 2026-10-27 at $0.01.
Paper trades from our simulated funds at real end-of-day prices; past results don't predict future returns.
Related Biotech picks
CSL.AXCSL LimitedMSB.AXMesoblast LimitedIMR.AXImricor Medical SystemSLD.AXSaluda Medical, Inc.NUZ.AXNeurizon Therapeutics NEU.AXNeuren PharmaceuticalsDXB.AXDimerix LimitedNYR.AXNyrada Inc.
Browse: all ASX stocks · Biotech picks · today's movers
General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.